Transfusion risk from emerging pathogens in the Asia–Pacific region
Identifieur interne : 001358 ( Istex/Corpus ); précédent : 001357; suivant : 001359Transfusion risk from emerging pathogens in the Asia–Pacific region
Auteurs : H. M. Faddy ; E. Viennet ; R. L. P. FlowerSource :
- ISBT Science Series [ 1751-2816 ] ; 2016-06.
Abstract
Background: An emerging infectious disease (EID) refers to a disease that has recently appeared in a population or one that has rapidly increased in incidence or geographic range. Examples of EIDs include Ebola, HIV/AIDS, hepatitis E and the vector‐borne diseases caused by Zika and dengue virus. EIDs pose a risk to transfusion safety, which can be direct, if the agent can be transmitted through blood transfusion, or indirect, where outbreaks reduce the pool of available donors. Although examples of both have been observed, the former will be the focus of this review. Many transfusion risks have become global due to globalization and increased international travel; however, unique region‐specific concerns exist. The Asia–Pacific region varies in size depending on context, but for the purposes of this review will be defined as South‐East Asia, East Asia and Oceania. This region is a hotspot for genetic diversity, as well as the emergence of a number of infectious diseases. The Asia–Pacific region is also geographically, culturally, socio‐economically and climatically diverse. Moreover, the level of sophistication in blood operators within this region varies, from a national supplier based on voluntary blood donors as is seen in Australia to hospital‐based services relying on replacement donors, which is seen in many nations across the Pacific. Aims: To review current EID risks to blood transfusion safety in the Asia–Pacific region. Methods: Review of available public health reports and literature for the occurrence of EIDs in the Asia–Pacific region that pose a transfusion risk. Results: EIDs that pose a transfusion risk occur across the Asia–Pacific region, with differing levels of endemicity between and within countries. Reports of hepatitis E virus (HEV) sero‐positivity vary from 2·2% in Fiji to 15·2% in Papua New Guinea. As a result of high HEV prevalence in the Hokkaido region of Japan, HEV nucleic acid amplification testing (NAT) has been implemented for screening blood donations. Dengue infection is widespread across the Asia–Pacific, with major outbreaks occurring in 2014 in Fiji, Malaysia, the Philippines and Thailand. In Australia, dengue is episodic in the north‐east, resulting in donation restrictions in affected areas. Zika virus emerged in the Asia–Pacific in early 2007 and outbreaks have spread across the Pacific, with epidemics in French Polynesia, the Cook Islands, Easter Island and New Caledonia. Due to the theoretical transfusion risk, several preventative procedures were implemented in French Polynesia during an outbreak in 2013, including NAT. Summary/conclusions: EIDs pose a transfusion risk globally, and in the Asia–Pacific region. A number of EIDs that can be transmitted through blood transfusion are endemic to the Asia–Pacific, with countries managing the transfusion risk depending on the level of endemicity of the agent in question, and the maturity of blood operations in each county. Climate change is predicted to increase the distribution and density of a range of disease vectors, which is likely to increase the transmission of a number of vector‐borne diseases, representing a significant threat to the maintenance of a safe blood supply in the future.
Url:
DOI: 10.1111/voxs.12247
Links to Exploration step
ISTEX:C3CE517249861FEC25DBB2BF205635EA45EA3B86Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Transfusion risk from emerging pathogens in the Asia–Pacific region</title><author><name sortKey="Faddy, H M" sort="Faddy, H M" uniqKey="Faddy H" first="H. M." last="Faddy">H. M. Faddy</name><affiliation><mods:affiliation>Research and Development, Australian Red Cross Blood Service, Brisbane, Qld, Australia</mods:affiliation></affiliation><affiliation><mods:affiliation>School of Medicine, The University of Queensland, Qld, Brisbane, Australia</mods:affiliation></affiliation><affiliation><mods:affiliation>Helen M. Faddy; 44 Musk Avenue, Kelvin Grove, Qld 4059, Australia.E‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: hfaddy@redcrossblood.org.au</mods:affiliation></affiliation></author><author><name sortKey="Viennet, E" sort="Viennet, E" uniqKey="Viennet E" first="E." last="Viennet">E. Viennet</name><affiliation><mods:affiliation>Australian National University, ACT, Canberra, Australia</mods:affiliation></affiliation></author><author><name sortKey="Flower, R L P" sort="Flower, R L P" uniqKey="Flower R" first="R. L. P." last="Flower">R. L. P. Flower</name><affiliation><mods:affiliation>Research and Development, Australian Red Cross Blood Service, Qld, Brisbane, Australia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C3CE517249861FEC25DBB2BF205635EA45EA3B86</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1111/voxs.12247</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-GK9RZ7N8-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001358</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001358</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Transfusion risk from emerging pathogens in the Asia–Pacific region</title><author><name sortKey="Faddy, H M" sort="Faddy, H M" uniqKey="Faddy H" first="H. M." last="Faddy">H. M. Faddy</name><affiliation><mods:affiliation>Research and Development, Australian Red Cross Blood Service, Brisbane, Qld, Australia</mods:affiliation></affiliation><affiliation><mods:affiliation>School of Medicine, The University of Queensland, Qld, Brisbane, Australia</mods:affiliation></affiliation><affiliation><mods:affiliation>Helen M. Faddy; 44 Musk Avenue, Kelvin Grove, Qld 4059, Australia.E‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: hfaddy@redcrossblood.org.au</mods:affiliation></affiliation></author><author><name sortKey="Viennet, E" sort="Viennet, E" uniqKey="Viennet E" first="E." last="Viennet">E. Viennet</name><affiliation><mods:affiliation>Australian National University, ACT, Canberra, Australia</mods:affiliation></affiliation></author><author><name sortKey="Flower, R L P" sort="Flower, R L P" uniqKey="Flower R" first="R. L. P." last="Flower">R. L. P. Flower</name><affiliation><mods:affiliation>Research and Development, Australian Red Cross Blood Service, Qld, Brisbane, Australia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">ISBT Science Series</title><title level="j" type="sub">26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</title><title level="j" type="alt">ISBT SCIENCE SERIES</title><idno type="ISSN">1751-2816</idno><idno type="eISSN">1751-2824</idno><imprint><biblScope unit="vol">11</biblScope><biblScope unit="issue">S2</biblScope><biblScope unit="page" from="143">143</biblScope><biblScope unit="page" to="148">148</biblScope><biblScope unit="page-count">6</biblScope><date type="published" when="2016-06">2016-06</date></imprint><idno type="ISSN">1751-2816</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1751-2816</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Background: An emerging infectious disease (EID) refers to a disease that has recently appeared in a population or one that has rapidly increased in incidence or geographic range. Examples of EIDs include Ebola, HIV/AIDS, hepatitis E and the vector‐borne diseases caused by Zika and dengue virus. EIDs pose a risk to transfusion safety, which can be direct, if the agent can be transmitted through blood transfusion, or indirect, where outbreaks reduce the pool of available donors. Although examples of both have been observed, the former will be the focus of this review. Many transfusion risks have become global due to globalization and increased international travel; however, unique region‐specific concerns exist. The Asia–Pacific region varies in size depending on context, but for the purposes of this review will be defined as South‐East Asia, East Asia and Oceania. This region is a hotspot for genetic diversity, as well as the emergence of a number of infectious diseases. The Asia–Pacific region is also geographically, culturally, socio‐economically and climatically diverse. Moreover, the level of sophistication in blood operators within this region varies, from a national supplier based on voluntary blood donors as is seen in Australia to hospital‐based services relying on replacement donors, which is seen in many nations across the Pacific. Aims: To review current EID risks to blood transfusion safety in the Asia–Pacific region. Methods: Review of available public health reports and literature for the occurrence of EIDs in the Asia–Pacific region that pose a transfusion risk. Results: EIDs that pose a transfusion risk occur across the Asia–Pacific region, with differing levels of endemicity between and within countries. Reports of hepatitis E virus (HEV) sero‐positivity vary from 2·2% in Fiji to 15·2% in Papua New Guinea. As a result of high HEV prevalence in the Hokkaido region of Japan, HEV nucleic acid amplification testing (NAT) has been implemented for screening blood donations. Dengue infection is widespread across the Asia–Pacific, with major outbreaks occurring in 2014 in Fiji, Malaysia, the Philippines and Thailand. In Australia, dengue is episodic in the north‐east, resulting in donation restrictions in affected areas. Zika virus emerged in the Asia–Pacific in early 2007 and outbreaks have spread across the Pacific, with epidemics in French Polynesia, the Cook Islands, Easter Island and New Caledonia. Due to the theoretical transfusion risk, several preventative procedures were implemented in French Polynesia during an outbreak in 2013, including NAT. Summary/conclusions: EIDs pose a transfusion risk globally, and in the Asia–Pacific region. A number of EIDs that can be transmitted through blood transfusion are endemic to the Asia–Pacific, with countries managing the transfusion risk depending on the level of endemicity of the agent in question, and the maturity of blood operations in each county. Climate change is predicted to increase the distribution and density of a range of disease vectors, which is likely to increase the transmission of a number of vector‐borne diseases, representing a significant threat to the maintenance of a safe blood supply in the future.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>H. M. Faddy</name><affiliations><json:string>Research and Development, Australian Red Cross Blood Service, Brisbane, Qld, Australia</json:string><json:string>School of Medicine, The University of Queensland, Qld, Brisbane, Australia</json:string><json:string>Helen M. Faddy; 44 Musk Avenue, Kelvin Grove, Qld 4059, Australia.E‐mail:</json:string><json:string>E-mail: hfaddy@redcrossblood.org.au</json:string></affiliations></json:item><json:item><name>E. Viennet</name><affiliations><json:string>Australian National University, ACT, Canberra, Australia</json:string></affiliations></json:item><json:item><name>R. L. P. Flower</name><affiliations><json:string>Research and Development, Australian Red Cross Blood Service, Qld, Brisbane, Australia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>blood transfusion</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dengue virus</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>emerging infectious disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>hepatitis E virus</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Pacific</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>safety</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Zika virus</value></json:item></subject><articleId><json:string>VOXS12247</json:string></articleId><arkIstex>ark:/67375/WNG-GK9RZ7N8-0</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><abstract>Background: An emerging infectious disease (EID) refers to a disease that has recently appeared in a population or one that has rapidly increased in incidence or geographic range. Examples of EIDs include Ebola, HIV/AIDS, hepatitis E and the vector‐borne diseases caused by Zika and dengue virus. EIDs pose a risk to transfusion safety, which can be direct, if the agent can be transmitted through blood transfusion, or indirect, where outbreaks reduce the pool of available donors. Although examples of both have been observed, the former will be the focus of this review. Many transfusion risks have become global due to globalization and increased international travel; however, unique region‐specific concerns exist. The Asia–Pacific region varies in size depending on context, but for the purposes of this review will be defined as South‐East Asia, East Asia and Oceania. This region is a hotspot for genetic diversity, as well as the emergence of a number of infectious diseases. The Asia–Pacific region is also geographically, culturally, socio‐economically and climatically diverse. Moreover, the level of sophistication in blood operators within this region varies, from a national supplier based on voluntary blood donors as is seen in Australia to hospital‐based services relying on replacement donors, which is seen in many nations across the Pacific. Aims: To review current EID risks to blood transfusion safety in the Asia–Pacific region. Methods: Review of available public health reports and literature for the occurrence of EIDs in the Asia–Pacific region that pose a transfusion risk. Results: EIDs that pose a transfusion risk occur across the Asia–Pacific region, with differing levels of endemicity between and within countries. Reports of hepatitis E virus (HEV) sero‐positivity vary from 2·2% in Fiji to 15·2% in Papua New Guinea. As a result of high HEV prevalence in the Hokkaido region of Japan, HEV nucleic acid amplification testing (NAT) has been implemented for screening blood donations. Dengue infection is widespread across the Asia–Pacific, with major outbreaks occurring in 2014 in Fiji, Malaysia, the Philippines and Thailand. In Australia, dengue is episodic in the north‐east, resulting in donation restrictions in affected areas. Zika virus emerged in the Asia–Pacific in early 2007 and outbreaks have spread across the Pacific, with epidemics in French Polynesia, the Cook Islands, Easter Island and New Caledonia. Due to the theoretical transfusion risk, several preventative procedures were implemented in French Polynesia during an outbreak in 2013, including NAT. Summary/conclusions: EIDs pose a transfusion risk globally, and in the Asia–Pacific region. A number of EIDs that can be transmitted through blood transfusion are endemic to the Asia–Pacific, with countries managing the transfusion risk depending on the level of endemicity of the agent in question, and the maturity of blood operations in each county. Climate change is predicted to increase the distribution and density of a range of disease vectors, which is likely to increase the transmission of a number of vector‐borne diseases, representing a significant threat to the maintenance of a safe blood supply in the future.</abstract><qualityIndicators><score>8.61</score><pdfWordCount>3610</pdfWordCount><pdfCharCount>22441</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>6</pdfPageCount><pdfPageSize>595.276 x 799.37 pts</pdfPageSize><pdfWordsPerPage>602</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>493</abstractWordCount><abstractCharCount>3235</abstractCharCount><keywordCount>7</keywordCount></qualityIndicators><title>Transfusion risk from emerging pathogens in the Asia–Pacific region</title><genre><json:string>review-article</json:string></genre><host><title>ISBT Science Series</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1751-2824</json:string></doi><issn><json:string>1751-2816</json:string></issn><eissn><json:string>1751-2824</json:string></eissn><publisherId><json:string>VOXS</json:string></publisherId><volume>11</volume><issue>S2</issue><pages><first>143</first><last>148</last><total>6</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Invited Review</value></json:item><json:item><value>26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-GK9RZ7N8-0</json:string></ark><categories><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2016</publicationDate><copyrightDate>2016</copyrightDate><doi><json:string>10.1111/voxs.12247</json:string></doi><id>C3CE517249861FEC25DBB2BF205635EA45EA3B86</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GK9RZ7N8-0/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GK9RZ7N8-0/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-GK9RZ7N8-0/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Transfusion risk from emerging pathogens in the Asia–Pacific region</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher><availability><licence>© 2016 International Society of Blood Transfusion</licence></availability><date type="published" when="2016-06"></date></publicationStmt><notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Transfusion risk from emerging pathogens in the Asia–Pacific region</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">H. M.</forename><surname>Faddy</surname></persName><affiliation><orgName type="division">Research and Development</orgName>
<orgName type="institution">Australian Red Cross Blood Service</orgName>
<address><settlement>Brisbane</settlement>
<region>Qld</region>
<country key="AU" xml:lang="en">AUSTRALIA</country></address></affiliation><affiliation><orgName type="division">School of Medicine</orgName>
<orgName type="institution">The University of Queensland</orgName>
<address><settlement>Brisbane</settlement>
<region>Qld</region>
<country key="AU" xml:lang="en">AUSTRALIA</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">E.</forename><surname>Viennet</surname></persName><affiliation><orgName type="institution">Australian National University</orgName>
<address><settlement>Canberra</settlement>
<region>ACT</region>
<country key="AU" xml:lang="en">AUSTRALIA</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">R. L. P.</forename><surname>Flower</surname></persName><affiliation><orgName type="division">Research and Development</orgName>
<orgName type="institution">Australian Red Cross Blood Service</orgName>
<address><settlement>Brisbane</settlement>
<region>Qld</region>
<country key="AU" xml:lang="en">AUSTRALIA</country></address></affiliation></author><idno type="istex">C3CE517249861FEC25DBB2BF205635EA45EA3B86</idno><idno type="ark">ark:/67375/WNG-GK9RZ7N8-0</idno><idno type="DOI">10.1111/voxs.12247</idno><idno type="unit">VOXS12247</idno><idno type="toTypesetVersion">file:VOXS.VOXS12247.pdf</idno></analytic><monogr><title level="j" type="main">ISBT Science Series</title><title level="j" type="sub">26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</title><title level="j" type="alt">ISBT SCIENCE SERIES</title><idno type="pISSN">1751-2816</idno><idno type="eISSN">1751-2824</idno><idno type="book-DOI">10.1111/(ISSN)1751-2824</idno><idno type="book-part-DOI">10.1111/voxs.2016.11.issue-S2</idno><idno type="product">VOXS</idno><imprint><biblScope unit="vol">11</biblScope><biblScope unit="issue">S2</biblScope><biblScope unit="page" from="143">143</biblScope><biblScope unit="page" to="148">148</biblScope><biblScope unit="page-count">6</biblScope><date type="published" when="2016-06"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract style="main" xml:id="voxs12247-abs-0001"><head>Background</head><p>An emerging infectious disease (<hi rend="fc">EID</hi>) refers to a disease that has recently appeared in a population or one that has rapidly increased in incidence or geographic range. Examples of <hi rend="fc">EID</hi>s include Ebola, <hi rend="fc">HIV</hi>/<hi rend="fc">AIDS</hi>, hepatitis E and the vector‐borne diseases caused by Zika and dengue virus. <hi rend="fc">EID</hi>s pose a risk to transfusion safety, which can be direct, if the agent can be transmitted through blood transfusion, or indirect, where outbreaks reduce the pool of available donors. Although examples of both have been observed, the former will be the focus of this review. Many transfusion risks have become global due to globalization and increased international travel; however, unique region‐specific concerns exist. The Asia–Pacific region varies in size depending on context, but for the purposes of this review will be defined as South‐East Asia, East Asia and Oceania. This region is a hotspot for genetic diversity, as well as the emergence of a number of infectious diseases. The Asia–Pacific region is also geographically, culturally, socio‐economically and climatically diverse. Moreover, the level of sophistication in blood operators within this region varies, from a national supplier based on voluntary blood donors as is seen in Australia to hospital‐based services relying on replacement donors, which is seen in many nations across the Pacific.</p><head>Aims</head><p>To review current <hi rend="fc">EID</hi> risks to blood transfusion safety in the Asia–Pacific region.</p><head>Methods</head><p>Review of available public health reports and literature for the occurrence of <hi rend="fc">EID</hi>s in the Asia–Pacific region that pose a transfusion risk.</p><head>Results</head><p><hi rend="fc">EID</hi>s that pose a transfusion risk occur across the Asia–Pacific region, with differing levels of endemicity between and within countries. Reports of hepatitis E virus (<hi rend="fc">HEV</hi>) sero‐positivity vary from 2·2% in Fiji to 15·2% in Papua New Guinea. As a result of high <hi rend="fc">HEV</hi> prevalence in the Hokkaido region of Japan, <hi rend="fc">HEV</hi> nucleic acid amplification testing (<hi rend="fc">NAT</hi>) has been implemented for screening blood donations. Dengue infection is widespread across the Asia–Pacific, with major outbreaks occurring in 2014 in Fiji, Malaysia, the Philippines and Thailand. In Australia, dengue is episodic in the north‐east, resulting in donation restrictions in affected areas. Zika virus emerged in the Asia–Pacific in early 2007 and outbreaks have spread across the Pacific, with epidemics in French Polynesia, the Cook Islands, Easter Island and New Caledonia. Due to the theoretical transfusion risk, several preventative procedures were implemented in French Polynesia during an outbreak in 2013, including <hi rend="fc">NAT</hi>.</p><head>Summary/conclusions</head><p><hi rend="fc">EID</hi>s pose a transfusion risk globally, and in the Asia–Pacific region. A number of <hi rend="fc">EID</hi>s that can be transmitted through blood transfusion are endemic to the Asia–Pacific, with countries managing the transfusion risk depending on the level of endemicity of the agent in question, and the maturity of blood operations in each county. Climate change is predicted to increase the distribution and density of a range of disease vectors, which is likely to increase the transmission of a number of vector‐borne diseases, representing a significant threat to the maintenance of a safe blood supply in the future.</p></abstract><textClass><keywords><term xml:id="voxs12247-kwd-0001">blood transfusion</term><term xml:id="voxs12247-kwd-0002">dengue virus</term><term xml:id="voxs12247-kwd-0003">emerging infectious disease</term><term xml:id="voxs12247-kwd-0004">hepatitis E virus</term><term xml:id="voxs12247-kwd-0005">Pacific</term><term xml:id="voxs12247-kwd-0006">safety</term><term xml:id="voxs12247-kwd-0007">Zika virus</term></keywords><keywords rend="articleCategory"><term>Invited Review</term></keywords><keywords rend="tocHeading1"><term>26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GK9RZ7N8-0/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:id="voxs12247" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1751-2824</doi><issn type="print">1751-2816</issn><issn type="electronic">1751-2824</issn><idGroup><id type="product" value="VOXS"></id></idGroup><titleGroup><title sort="ISBT SCIENCE SERIES" type="main">ISBT Science Series</title><title type="short">VOXS</title></titleGroup></publicationMeta><publicationMeta level="part" position="18"><doi origin="wiley">10.1111/voxs.2016.11.issue-S2</doi><titleGroup><title type="specialIssueTitle">26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</title></titleGroup><copyright ownership="thirdParty">Copyright ISBT Science Series © 2016 International Society of Blood Transfusion</copyright><numberingGroup><numbering number="11" type="journalVolume">11</numbering><numbering type="journalIssue">S2</numbering></numberingGroup><coverDate startDate="2016-06">June 2016</coverDate></publicationMeta><publicationMeta level="unit" position="260" status="forIssue" type="reviewArticle"><doi>10.1111/voxs.12247</doi><idGroup><id type="unit" value="VOXS12247"></id></idGroup><countGroup><count number="6" type="pageTotal"></count></countGroup><titleGroup><title type="articleCategory">Invited Review<link href="#voxs12247-note-0101"></link></title><title type="tocHeading1">26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</title></titleGroup><copyright ownership="thirdParty">© 2016 International Society of Blood Transfusion</copyright><eventGroup><event agent="SPS" date="2015-12-17" type="xmlCreated"></event><event agent="SPS" date="2016-12-24" type="xmlCorrected"></event><event type="firstOnline" date="2016-06-28"></event><event type="publishedOnlineFinalForm" date="2016-06-28"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:5.0.6 mode:FullText" date="2017-02-10"></event></eventGroup><numberingGroup><numbering type="pageFirst">143</numbering><numbering type="pageLast">148</numbering></numberingGroup><correspondenceTo><lineatedText><line><i>Correspondence:</i> Helen M. Faddy; 44 Musk Avenue, Kelvin Grove, Qld 4059, Australia.</line><line>E‐mail: <email>hfaddy@redcrossblood.org.au</email></line></lineatedText></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:VOXS.VOXS12247.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Transfusion risk from emerging pathogens in the Asia–Pacific region</title><title type="shortAuthors">H. M. Faddy <i>et al</i>.</title></titleGroup><creators><creator affiliationRef="#voxs12247-aff-0001 #voxs12247-aff-0002" corresponding="yes" creatorRole="author" xml:id="voxs12247-cr-0001"><personName><givenNames>H. M.</givenNames> <familyName>Faddy</familyName></personName></creator><creator affiliationRef="#voxs12247-aff-0003" creatorRole="author" xml:id="voxs12247-cr-0002"><personName><givenNames>E.</givenNames> <familyName>Viennet</familyName></personName></creator><creator affiliationRef="#voxs12247-aff-0001" creatorRole="author" xml:id="voxs12247-cr-0003"><personName><givenNames>R. L. P.</givenNames> <familyName>Flower</familyName></personName></creator></creators><affiliationGroup><affiliation countryCode="AU" type="organization" xml:id="voxs12247-aff-0001"><orgDiv>Research and Development</orgDiv> <orgName>Australian Red Cross Blood Service</orgName> <address><city>Brisbane</city> <countryPart>Qld</countryPart> <country>Australia</country></address></affiliation><affiliation countryCode="AU" type="organization" xml:id="voxs12247-aff-0002"><orgDiv>School of Medicine</orgDiv> <orgName>The University of Queensland</orgName> <address><city>Brisbane</city> <countryPart>Qld</countryPart> <country>Australia</country></address></affiliation><affiliation countryCode="AU" type="organization" xml:id="voxs12247-aff-0003"><orgName>Australian National University</orgName> <address><city>Canberra</city> <countryPart>ACT</countryPart> <country>Australia</country></address></affiliation></affiliationGroup><keywordGroup type="author"><keyword xml:id="voxs12247-kwd-0001">blood transfusion</keyword><keyword xml:id="voxs12247-kwd-0002">dengue virus</keyword><keyword xml:id="voxs12247-kwd-0003">emerging infectious disease</keyword><keyword xml:id="voxs12247-kwd-0004">hepatitis E virus</keyword><keyword xml:id="voxs12247-kwd-0005">Pacific</keyword><keyword xml:id="voxs12247-kwd-0006">safety</keyword><keyword xml:id="voxs12247-kwd-0007">Zika virus</keyword></keywordGroup><fundingInfo><fundingAgency>Australian governments</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:id="voxs12247-abs-0001"><section xml:id="voxs12247-sec-0001"><title type="main">Background</title><p>An emerging infectious disease (<fc>EID</fc>) refers to a disease that has recently appeared in a population or one that has rapidly increased in incidence or geographic range. Examples of <fc>EID</fc>s include Ebola, <fc>HIV</fc>/<fc>AIDS</fc>, hepatitis E and the vector‐borne diseases caused by Zika and dengue virus. <fc>EID</fc>s pose a risk to transfusion safety, which can be direct, if the agent can be transmitted through blood transfusion, or indirect, where outbreaks reduce the pool of available donors. Although examples of both have been observed, the former will be the focus of this review. Many transfusion risks have become global due to globalization and increased international travel; however, unique region‐specific concerns exist. The Asia–Pacific region varies in size depending on context, but for the purposes of this review will be defined as South‐East Asia, East Asia and Oceania. This region is a hotspot for genetic diversity, as well as the emergence of a number of infectious diseases. The Asia–Pacific region is also geographically, culturally, socio‐economically and climatically diverse. Moreover, the level of sophistication in blood operators within this region varies, from a national supplier based on voluntary blood donors as is seen in Australia to hospital‐based services relying on replacement donors, which is seen in many nations across the Pacific.</p></section><section xml:id="voxs12247-sec-0002"><title type="main">Aims</title><p>To review current <fc>EID</fc> risks to blood transfusion safety in the Asia–Pacific region.</p></section><section xml:id="voxs12247-sec-0003"><title type="main">Methods</title><p>Review of available public health reports and literature for the occurrence of <fc>EID</fc>s in the Asia–Pacific region that pose a transfusion risk.</p></section><section xml:id="voxs12247-sec-0004"><title type="main">Results</title><p><fc>EID</fc>s that pose a transfusion risk occur across the Asia–Pacific region, with differing levels of endemicity between and within countries. Reports of hepatitis E virus (<fc>HEV</fc>) sero‐positivity vary from 2·2% in Fiji to 15·2% in Papua New Guinea. As a result of high <fc>HEV</fc> prevalence in the Hokkaido region of Japan, <fc>HEV</fc> nucleic acid amplification testing (<fc>NAT</fc>) has been implemented for screening blood donations. Dengue infection is widespread across the Asia–Pacific, with major outbreaks occurring in 2014 in Fiji, Malaysia, the Philippines and Thailand. In Australia, dengue is episodic in the north‐east, resulting in donation restrictions in affected areas. Zika virus emerged in the Asia–Pacific in early 2007 and outbreaks have spread across the Pacific, with epidemics in French Polynesia, the Cook Islands, Easter Island and New Caledonia. Due to the theoretical transfusion risk, several preventative procedures were implemented in French Polynesia during an outbreak in 2013, including <fc>NAT</fc>.</p></section><section xml:id="voxs12247-sec-0005"><title type="main">Summary/conclusions</title><p><fc>EID</fc>s pose a transfusion risk globally, and in the Asia–Pacific region. A number of <fc>EID</fc>s that can be transmitted through blood transfusion are endemic to the Asia–Pacific, with countries managing the transfusion risk depending on the level of endemicity of the agent in question, and the maturity of blood operations in each county. Climate change is predicted to increase the distribution and density of a range of disease vectors, which is likely to increase the transmission of a number of vector‐borne diseases, representing a significant threat to the maintenance of a safe blood supply in the future.</p></section></abstract></abstractGroup></contentMeta><noteGroup xml:id="voxs12247-ntgp-0101"><note xml:id="voxs12247-note-0101">3B‐S11‐04</note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Transfusion risk from emerging pathogens in the Asia–Pacific region</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Transfusion risk from emerging pathogens in the Asia–Pacific region</title></titleInfo><name type="personal"><namePart type="given">H. M.</namePart><namePart type="family">Faddy</namePart><affiliation>Research and Development, Australian Red Cross Blood Service, Brisbane, Qld, Australia</affiliation><affiliation>School of Medicine, The University of Queensland, Qld, Brisbane, Australia</affiliation><affiliation>Helen M. Faddy; 44 Musk Avenue, Kelvin Grove, Qld 4059, Australia.E‐mail:</affiliation><affiliation>E-mail: hfaddy@redcrossblood.org.au</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Viennet</namePart><affiliation>Australian National University, ACT, Canberra, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R. L. P.</namePart><namePart type="family">Flower</namePart><affiliation>Research and Development, Australian Red Cross Blood Service, Qld, Brisbane, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2016-06</dateIssued><dateCreated encoding="w3cdtf">2015-12-17</dateCreated><copyrightDate encoding="w3cdtf">2016</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract>Background: An emerging infectious disease (EID) refers to a disease that has recently appeared in a population or one that has rapidly increased in incidence or geographic range. Examples of EIDs include Ebola, HIV/AIDS, hepatitis E and the vector‐borne diseases caused by Zika and dengue virus. EIDs pose a risk to transfusion safety, which can be direct, if the agent can be transmitted through blood transfusion, or indirect, where outbreaks reduce the pool of available donors. Although examples of both have been observed, the former will be the focus of this review. Many transfusion risks have become global due to globalization and increased international travel; however, unique region‐specific concerns exist. The Asia–Pacific region varies in size depending on context, but for the purposes of this review will be defined as South‐East Asia, East Asia and Oceania. This region is a hotspot for genetic diversity, as well as the emergence of a number of infectious diseases. The Asia–Pacific region is also geographically, culturally, socio‐economically and climatically diverse. Moreover, the level of sophistication in blood operators within this region varies, from a national supplier based on voluntary blood donors as is seen in Australia to hospital‐based services relying on replacement donors, which is seen in many nations across the Pacific. Aims: To review current EID risks to blood transfusion safety in the Asia–Pacific region. Methods: Review of available public health reports and literature for the occurrence of EIDs in the Asia–Pacific region that pose a transfusion risk. Results: EIDs that pose a transfusion risk occur across the Asia–Pacific region, with differing levels of endemicity between and within countries. Reports of hepatitis E virus (HEV) sero‐positivity vary from 2·2% in Fiji to 15·2% in Papua New Guinea. As a result of high HEV prevalence in the Hokkaido region of Japan, HEV nucleic acid amplification testing (NAT) has been implemented for screening blood donations. Dengue infection is widespread across the Asia–Pacific, with major outbreaks occurring in 2014 in Fiji, Malaysia, the Philippines and Thailand. In Australia, dengue is episodic in the north‐east, resulting in donation restrictions in affected areas. Zika virus emerged in the Asia–Pacific in early 2007 and outbreaks have spread across the Pacific, with epidemics in French Polynesia, the Cook Islands, Easter Island and New Caledonia. Due to the theoretical transfusion risk, several preventative procedures were implemented in French Polynesia during an outbreak in 2013, including NAT. Summary/conclusions: EIDs pose a transfusion risk globally, and in the Asia–Pacific region. A number of EIDs that can be transmitted through blood transfusion are endemic to the Asia–Pacific, with countries managing the transfusion risk depending on the level of endemicity of the agent in question, and the maturity of blood operations in each county. Climate change is predicted to increase the distribution and density of a range of disease vectors, which is likely to increase the transmission of a number of vector‐borne diseases, representing a significant threat to the maintenance of a safe blood supply in the future.</abstract><note type="funding">Australian governments</note><subject><genre>keywords</genre><topic>blood transfusion</topic><topic>dengue virus</topic><topic>emerging infectious disease</topic><topic>hepatitis E virus</topic><topic>Pacific</topic><topic>safety</topic><topic>Zika virus</topic></subject><relatedItem type="host"><titleInfo><title>ISBT Science Series</title></titleInfo><titleInfo type="abbreviated"><title>VOXS</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Invited Review</topic><topic>26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</topic></subject><identifier type="ISSN">1751-2816</identifier><identifier type="eISSN">1751-2824</identifier><identifier type="DOI">10.1111/(ISSN)1751-2824</identifier><identifier type="PublisherID">VOXS</identifier><part><date>2016</date><detail type="title"><title>26th Regional Congress of the International Society of Blood Transfusion Nusa Dua, Bali, Indonesia November 14–16, 2015</title></detail><detail type="volume"><caption>vol.</caption><number>11</number></detail><detail type="issue"><caption>no.</caption><number>S2</number></detail><extent unit="pages"><start>143</start><end>148</end><total>6</total></extent></part></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0001"><titleInfo><title>Emerging infections: a perpetual challenge</title></titleInfo><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Morens</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GK</namePart><namePart type="family">Folkers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Fauci</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Morens DM, Folkers GK, Fauci AS: Emerging infections: a perpetual challenge. Lancet Infect Dis 2008; 8:710–719</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>710</start><end>719</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet Infect Dis</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>710</start><end>719</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0002"><titleInfo><title>Ecological origins of novel human pathogens</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Woolhouse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Gaunt</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Woolhouse M, Gaunt E: Ecological origins of novel human pathogens. Crit Rev Microbiol 2007; 33:231–242</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>231</start><end>242</end></extent></part><relatedItem type="host"><titleInfo><title>Crit Rev Microbiol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>231</start><end>242</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0003"><titleInfo><title>Emerging infectious disease agents and their potential threat to transfusion safety</title></titleInfo><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Stramer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FB</namePart><namePart type="family">Hollinger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Katz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stramer SL, Hollinger FB, Katz LM, et al.: Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49(Suppl. 2):1S–29S</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 2</number></detail><extent unit="pages"><start>1S</start><end>29S</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>49</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 2</number></detail><extent unit="pages"><start>1S</start><end>29S</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0004"><titleInfo><title>The effect of riboflavin and ultraviolet light on the infectivity of arboviruses</title></titleInfo><name type="personal"><namePart type="given">HM</namePart><namePart type="family">Faddy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NA</namePart><namePart type="family">Prow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Fryk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Faddy HM, Prow NA, Fryk JJ, et al.: The effect of riboflavin and ultraviolet light on the infectivity of arboviruses. Transfusion 2014; doi:10.1111/trf.12899</note><part><date>2014</date></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2014</date></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0005"><titleInfo><title>Prospects for emerging infections in East and southeast Asia 10 years after severe acute respiratory syndrome</title></titleInfo><name type="personal"><namePart type="given">PW</namePart><namePart type="family">Horby</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Pfeiffer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Oshitani</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Horby PW, Pfeiffer D, Oshitani H: Prospects for emerging infections in East and southeast Asia 10 years after severe acute respiratory syndrome. Emerg Infect Dis 2013; 19:853–860</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>853</start><end>860</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>853</start><end>860</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0006"><titleInfo><title>Preparing for the next pandemic</title></titleInfo><name type="personal"><namePart type="given">MT</namePart><namePart type="family">Osterholm</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Osterholm MT: Preparing for the next pandemic. N Engl J Med 2005; 352:1839–1842</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>352</number></detail><extent unit="pages"><start>1839</start><end>1842</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>352</number></detail><extent unit="pages"><start>1839</start><end>1842</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0007"><titleInfo><title>Hepatitis E: source and route of infection, clinical manifestations and new developments</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Scobie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HR</namePart><namePart type="family">Dalton</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Scobie L, Dalton HR: Hepatitis E: source and route of infection, clinical manifestations and new developments. J Viral Hepatitis 2013; 20:1–11</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1</start><end>11</end></extent></part><relatedItem type="host"><titleInfo><title>J Viral Hepatitis</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1</start><end>11</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0008"><titleInfo><title>Hepatitis E</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Kamar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Bendall</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Legrand‐Abravanel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kamar N, Bendall R, Legrand‐Abravanel F, et al.: Hepatitis E. Lancet 2012; 379:2477–2488</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>379</number></detail><extent unit="pages"><start>2477</start><end>2488</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>379</number></detail><extent unit="pages"><start>2477</start><end>2488</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0009"><titleInfo><title>Pavio N, Bouquet J: Zoonotic Hepatitis E; Viral Infections and Global Change. Hoboken, NJ., John Wiley & Sons, Inc, 2013: 445–465.</title></titleInfo><note type="citation/reference">Pavio N, Bouquet J: Zoonotic Hepatitis E; Viral Infections and Global Change. Hoboken, NJ., John Wiley & Sons, Inc, 2013: 445–465.</note><name type="personal"><namePart type="given">N</namePart><namePart type="family">Pavio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Bouquet</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>John Wiley & Sons, Inc</publisher><place><placeTerm type="text">Hoboken, NJ.</placeTerm></place></originInfo><part><date>2013</date><extent unit="pages"><start>445</start><end>465</end></extent></part></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0010"><titleInfo><title>Clinical presentation of hepatitis E</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Aggarwal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Aggarwal R: Clinical presentation of hepatitis E. Virus Res 2011; 161:15–22</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>15</start><end>22</end></extent></part><relatedItem type="host"><titleInfo><title>Virus Res</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>161</number></detail><extent unit="pages"><start>15</start><end>22</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0011"><titleInfo><title>Chronic hepatitis E virus infection and treatment</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Kamar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Izopet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HR</namePart><namePart type="family">Dalton</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kamar N, Izopet J, Dalton HR: Chronic hepatitis E virus infection and treatment. J Clin Exp Hepatol 2013; 3:134–140</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>134</start><end>140</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Exp Hepatol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>134</start><end>140</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0012"><titleInfo><title>Hepatitis E virus and implications for blood supply safety, Australia</title></titleInfo><name type="personal"><namePart type="given">AC</namePart><namePart type="family">Shrestha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CR</namePart><namePart type="family">Seed</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RL</namePart><namePart type="family">Flower</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shrestha AC, Seed CR, Flower RL, et al.: Hepatitis E virus and implications for blood supply safety, Australia. Emerg Infect Dis 2014; 20:1940–1942</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1940</start><end>1942</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1940</start><end>1942</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0013"><titleInfo><title>Hepatitis E virus infection, Papua New Guinea, Fiji, and Kiribati, 2003–2005</title></titleInfo><name type="personal"><namePart type="given">JS</namePart><namePart type="family">Halliday</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GL</namePart><namePart type="family">Harrison</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Brown</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Halliday JS, Harrison GL, Brown A, et al.: Hepatitis E virus infection, Papua New Guinea, Fiji, and Kiribati, 2003–2005. Emerg Infect Dis 2014; 20:1057–1058</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1057</start><end>1058</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1057</start><end>1058</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0014"><titleInfo><title>Transfusion‐associated hepatitis E, France</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Colson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Coze</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Gallian</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Colson P, Coze C, Gallian P, et al.: Transfusion‐associated hepatitis E, France. Emerg Infect Dis 2007; 13:648–649</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>648</start><end>649</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>648</start><end>649</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0015"><titleInfo><title>Hepatitis E virus in blood components: a prevalence and transmission study in southeast England</title></titleInfo><name type="personal"><namePart type="given">PE</namePart><namePart type="family">Hewitt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Ijaz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SR</namePart><namePart type="family">Brailsford</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hewitt PE, Ijaz S, Brailsford SR, et al.: Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384:1766–1773</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>384</number></detail><extent unit="pages"><start>1766</start><end>1773</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>384</number></detail><extent unit="pages"><start>1766</start><end>1773</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0016"><titleInfo><title>Transfusion‐transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Matsubayashi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Nagaoka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Sakata</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Matsubayashi K, Nagaoka Y, Sakata H, et al.: Transfusion‐transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44:934–940</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>934</start><end>940</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>934</start><end>940</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0017"><titleInfo><title>Hepatitis E transmission by transfusion of Intercept blood system‐treated plasma</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Hauser</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Roque‐Afonso</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Beyloune</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hauser L, Roque‐Afonso AM, Beyloune A, et al.: Hepatitis E transmission by transfusion of Intercept blood system‐treated plasma. Blood 2014; 123:796–797</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>123</number></detail><extent unit="pages"><start>796</start><end>797</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>123</number></detail><extent unit="pages"><start>796</start><end>797</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0018"><titleInfo><title>Should we screen blood products for hepatitis E virus RNA?</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Feray</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Pawlotsky</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Roque‐Afonso</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Feray C, Pawlotsky JM, Roque‐Afonso AM, et al.: Should we screen blood products for hepatitis E virus RNA? Lancet 2014; 383:218</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>383</number></detail><extent unit="pages"><start>218</start></extent></part><relatedItem type="host"><titleInfo><title>Lancet</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>383</number></detail><extent unit="pages"><start>218</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0019"><titleInfo><title>The dengue viruses</title></titleInfo><name type="personal"><namePart type="given">EA</namePart><namePart type="family">Henchal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Putnak</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Henchal EA, Putnak JR: The dengue viruses. Clin Microbiol Rev 1990; 3:376–396</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>376</start><end>396</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Microbiol Rev</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>376</start><end>396</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0020"><titleInfo><title>Discovery of fifth serotype of dengue virus (DENV‐5): a new public health dilemma in dengue control</title></titleInfo><name type="personal"><namePart type="given">MS</namePart><namePart type="family">Mustafa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Rasotgi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mustafa MS, Rasotgi V, Jain S, et al.: Discovery of fifth serotype of dengue virus (DENV‐5): a new public health dilemma in dengue control. Med J Armed Forces India 2015; 71:67–70</note><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>71</number></detail><extent unit="pages"><start>67</start><end>70</end></extent></part><relatedItem type="host"><titleInfo><title>Med J Armed Forces India</title></titleInfo><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>71</number></detail><extent unit="pages"><start>67</start><end>70</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0021"><titleInfo><title>Blood supply under threat</title></titleInfo><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Semenza</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Domanović</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Semenza JC, Domanović D: Blood supply under threat. Nat Clim Chang 2013; 3:432–435</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>432</start><end>435</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Clim Chang</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>432</start><end>435</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0022"><titleInfo><title>Dengue and dengue hemorrhagic fever</title></titleInfo><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">Gubler</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480–496</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>480</start><end>496</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Microbiol Rev</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>480</start><end>496</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0023"><titleInfo><title>Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand</title></titleInfo><name type="personal"><namePart type="given">TP</namePart><namePart type="family">Endy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Chunsuttiwat</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Nisalak</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Endy TP, Chunsuttiwat S, Nisalak A, et al.: Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40–51</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>40</start><end>51</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Epidemiol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>40</start><end>51</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0024"><titleInfo><title>Risk factors for dengue infection during an outbreak in Yanes, Puerto Rico in 1991</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Rodriguez‐Figueroa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JG</namePart><namePart type="family">Rigau‐Perez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EL</namePart><namePart type="family">Suarez</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rodriguez‐Figueroa L, Rigau‐Perez JG, Suarez EL, et al.: Risk factors for dengue infection during an outbreak in Yanes, Puerto Rico in 1991. Am J Trop Med Hyg 1995; 52:496–502</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>496</start><end>502</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Trop Med Hyg</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>496</start><end>502</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0025"><titleInfo><title>A prospective study of dengue infections in Bangkok</title></titleInfo><name type="personal"><namePart type="given">DS</namePart><namePart type="family">Burke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Nisalak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DE</namePart><namePart type="family">Johnson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Burke DS, Nisalak A, Johnson DE, et al.: A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 1988; 38:172–180</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>172</start><end>180</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Trop Med Hyg</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>172</start><end>180</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0026"><titleInfo><title>Dengue vaccine development: strategies and challenges</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Ramakrishnan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Pillai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RR</namePart><namePart type="family">Nair</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ramakrishnan L, Pillai MR, Nair RR: Dengue vaccine development: strategies and challenges. Viral Immunol 2015; 28:76–84</note><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>76</start><end>84</end></extent></part><relatedItem type="host"><titleInfo><title>Viral Immunol</title></titleInfo><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>76</start><end>84</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0027"><titleInfo><title>The global distribution and burden of dengue</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Bhatt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PW</namePart><namePart type="family">Gething</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OJ</namePart><namePart type="family">Brady</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bhatt S, Gething PW, Brady OJ, et al.: The global distribution and burden of dengue. Nature 2013; 496:504–507</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>496</number></detail><extent unit="pages"><start>504</start><end>507</end></extent></part><relatedItem type="host"><titleInfo><title>Nature</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>496</number></detail><extent unit="pages"><start>504</start><end>507</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0028"><titleInfo><title>Epidemiological update on the dengue situation in the Western Pacific Region, 2012</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Arima</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Chiew</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Matsui</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Arima Y, Chiew M, Matsui T: Epidemiological update on the dengue situation in the Western Pacific Region, 2012. Western Pac Surveill Response J 2015; 6:82–89</note><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>82</start><end>89</end></extent></part><relatedItem type="host"><titleInfo><title>Western Pac Surveill Response J</title></titleInfo><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>82</start><end>89</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0029"><titleInfo><title>Epidemiology of dengue in a high‐income country: a case study in Queensland, Australia</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Viennet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Ritchie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HM</namePart><namePart type="family">Faddy</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Viennet E, Ritchie SA, Faddy HM, et al.: Epidemiology of dengue in a high‐income country: a case study in Queensland, Australia. Parasit Vectors 2014; 7:379</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>379</start></extent></part><relatedItem type="host"><titleInfo><title>Parasit Vectors</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>379</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0030"><titleInfo><title>Dengue in the context of “safe blood” and global epidemiology: to screen or not to screen?</title></titleInfo><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Lanteri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Busch</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lanteri MC, Busch MP: Dengue in the context of “safe blood” and global epidemiology: to screen or not to screen? Transfusion 2012; 52:1634–1639</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>1634</start><end>1639</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>1634</start><end>1639</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0031"><titleInfo><title>Real‐time symptomatic case of transfusion‐transmitted dengue</title></titleInfo><name type="personal"><namePart type="given">JE</namePart><namePart type="family">Levi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Nishiya</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AC</namePart><namePart type="family">Felix</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Levi JE, Nishiya A, Felix AC, et al.: Real‐time symptomatic case of transfusion‐transmitted dengue. Transfusion 2015; 55:961–964</note><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>961</start><end>964</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>55</number></detail><extent unit="pages"><start>961</start><end>964</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0032"><titleInfo><title>Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico</title></titleInfo><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Stramer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Linnen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Carrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stramer SL, Linnen JM, Carrick JM, et al.: Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012; 52:1657–1666</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>1657</start><end>1666</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>1657</start><end>1666</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0033"><titleInfo><title>Dengue viremia in blood donors from Honduras, Brazil, and Australia</title></titleInfo><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Linnen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Vinelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EC</namePart><namePart type="family">Sabino</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Linnen JM, Vinelli E, Sabino EC, et al.: Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 2008; 48:1355–1362</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>1355</start><end>1362</end></extent></part><relatedItem type="host"><titleInfo><title>Transfusion</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>48</number></detail><extent unit="pages"><start>1355</start><end>1362</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0034"><titleInfo><title>The THERAFLEX UV‐Platelets technology effectively inactivates dengue viruses in platelet concentrates.</title></titleInfo><name type="personal"><namePart type="given">HM</namePart><namePart type="family">Faddy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Fryk</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PR</namePart><namePart type="family">Young</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Faddy HM, Fryk JJ, Young PR, et al.: The THERAFLEX UV‐Platelets technology effectively inactivates dengue viruses in platelet concentrates.. Vox Sang 2014; 107(Suppl. 1):125</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>107</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 1</number></detail><extent unit="pages"><start>125</start></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>107</number></detail><detail type="issue"><caption>no.</caption><number>Suppl. 1</number></detail><extent unit="pages"><start>125</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0035"><titleInfo><title>Is dengue a threat to the blood supply?</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Teo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LC</namePart><namePart type="family">Ng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Lam</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Teo D, Ng LC, Lam S: Is dengue a threat to the blood supply? Transfus Med 2009; 19:66–77</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>66</start><end>77</end></extent></part><relatedItem type="host"><titleInfo><title>Transfus Med</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>66</start><end>77</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0036"><titleInfo><title>Implications of dengue outbreaks for blood supply, Australia</title></titleInfo><name type="personal"><namePart type="given">HM</namePart><namePart type="family">Faddy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CR</namePart><namePart type="family">Seed</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Fryk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Faddy HM, Seed CR, Fryk JJ, et al.: Implications of dengue outbreaks for blood supply, Australia. Emerg Infect Dis 2013; 19:787–789</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>787</start><end>789</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>787</start><end>789</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0037"><titleInfo><title>NZBlood</title></titleInfo><genre>other</genre><part><date>2014</date></part></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0038"><titleInfo><title>Zika virus outside Africa</title></titleInfo><name type="personal"><namePart type="given">EB</namePart><namePart type="family">Hayes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hayes EB: Zika virus outside Africa. Emerg Infect Dis 2009; 15:1347–1350</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1347</start><end>1350</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1347</start><end>1350</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0039"><titleInfo><title>Zika virus, a cause of fever in Central Java, Indonesia</title></titleInfo><name type="personal"><namePart type="given">JG</namePart><namePart type="family">Olson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TG</namePart><namePart type="family">Ksiazek</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="family">Suhandiman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Olson JG, Ksiazek TG, Suhandiman, et al.: Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 1981; 75:389–93</note><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>75</number></detail><extent unit="pages"><start>389</start><end>93</end></extent></part><relatedItem type="host"><titleInfo><title>Trans R Soc Trop Med Hyg</title></titleInfo><part><date>1981</date><detail type="volume"><caption>vol.</caption><number>75</number></detail><extent unit="pages"><start>389</start><end>93</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0040"><titleInfo><title>Zika virus outbreak on Yap Island, Federated States of Micronesia</title></titleInfo><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Duffy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TH</namePart><namePart type="family">Chen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WT</namePart><namePart type="family">Hancock</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Duffy MR, Chen TH, Hancock WT, et al.: Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360:2536–2543</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>360</number></detail><extent unit="pages"><start>2536</start><end>2543</end></extent></part><relatedItem type="host"><titleInfo><title>N Engl J Med</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>360</number></detail><extent unit="pages"><start>2536</start><end>2543</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0041"><titleInfo><title>Rapid spread of emerging Zika virus in the Pacific area</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Musso</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EJ</namePart><namePart type="family">Nilles</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">VM</namePart><namePart type="family">Cao‐Lormeau</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Musso D, Nilles EJ, Cao‐Lormeau VM: Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 2014; 20:O595–O596</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>O595</start><end>O596</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Microbiol Infect</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>O595</start><end>O596</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0042"><titleInfo><title>Zika virus infection complicated by Guillain‐Barre syndrome–case report, French Polynesia, December 2013</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Oehler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Watrin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Larre</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oehler E, Watrin L, Larre P, et al.: Zika virus infection complicated by Guillain‐Barre syndrome–case report, French Polynesia, December 2013. Euro Surveill 2014; 19(9):20720.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>9</number></detail></part><relatedItem type="host"><titleInfo><title>Euro Surveill</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>9</number></detail></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0043"><titleInfo><title>Zika virus, French polynesia, South pacific, 2013</title></titleInfo><name type="personal"><namePart type="given">VM</namePart><namePart type="family">Cao‐Lormeau</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Roche</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Teissier</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cao‐Lormeau VM, Roche C, Teissier A, et al.: Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis 2014; 20:1085–1086</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1085</start><end>1086</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1085</start><end>1086</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0044"><titleInfo><title>Co‐infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Dupont‐Rouzeyrol</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">O'Connor</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Calvez</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dupont‐Rouzeyrol M, O'Connor O, Calvez E, et al.: Co‐infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014. Emerg Infect Dis 2015; 21:381–382</note><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>381</start><end>382</end></extent></part><relatedItem type="host"><titleInfo><title>Emerg Infect Dis</title></titleInfo><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>381</start><end>382</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0045"><titleInfo><title>Concurrent outbreaks of dengue, chikungunya and Zika virus infections ‐ an unprecedented epidemic wave of mosquito‐borne viruses in the Pacific 2012–2014</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Roth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Mercier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Lepers</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Roth A, Mercier A, Lepers C, et al.: Concurrent outbreaks of dengue, chikungunya and Zika virus infections ‐ an unprecedented epidemic wave of mosquito‐borne viruses in the Pacific 2012–2014. Euro Surveill 2014; 19(41):20929.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>41</number></detail></part><relatedItem type="host"><titleInfo><title>Euro Surveill</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>41</number></detail></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0046"><titleInfo><title>Transfusion‐transmitted arboviruses</title></titleInfo><name type="personal"><namePart type="given">LR</namePart><namePart type="family">Petersen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Busch</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Petersen LR, Busch MP: Transfusion‐transmitted arboviruses. Vox Sang 2010; 98:495–503</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>495</start><end>503</end></extent></part><relatedItem type="host"><titleInfo><title>Vox Sang</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>495</start><end>503</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0047"><titleInfo><title>First reported case of transfusion‐transmitted Ross River virus infection</title></titleInfo><name type="personal"><namePart type="given">VC</namePart><namePart type="family">Hoad</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">Speers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Keller</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hoad VC, Speers DJ, Keller AJ, et al.: First reported case of transfusion‐transmitted Ross River virus infection. Med J Aust 2015; 202:267–270</note><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>202</number></detail><extent unit="pages"><start>267</start><end>270</end></extent></part><relatedItem type="host"><titleInfo><title>Med J Aust</title></titleInfo><part><date>2015</date><detail type="volume"><caption>vol.</caption><number>202</number></detail><extent unit="pages"><start>267</start><end>270</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0048"><titleInfo><title>Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Musso</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Nhan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Robin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Musso D, Nhan T, Robin E, et al.: Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014; 19(14):20761</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>14</number></detail></part><relatedItem type="host"><titleInfo><title>Euro Surveill</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>14</number></detail></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="voxs12247-cit-0049"><titleInfo><title>Imported zika virus infection from the cook islands into Australia, 2014</title></titleInfo><name type="personal"><namePart type="given">AT</namePart><namePart type="family">Pyke</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MT</namePart><namePart type="family">Daly</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JN</namePart><namePart type="family">Cameron</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pyke AT, Daly MT, Cameron JN, et al.: Imported zika virus infection from the cook islands into Australia, 2014. PLOS Currents Outbreaks 2014; Jun 2 . Edition 1. doi: 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e.</note><part><date>2014</date></part><relatedItem type="host"><titleInfo><title>PLOS Currents Outbreaks</title></titleInfo><part><date>2014</date></part></relatedItem></relatedItem><identifier type="istex">C3CE517249861FEC25DBB2BF205635EA45EA3B86</identifier><identifier type="ark">ark:/67375/WNG-GK9RZ7N8-0</identifier><identifier type="DOI">10.1111/voxs.12247</identifier><identifier type="ArticleID">VOXS12247</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright ISBT Science Series © 2016 International Society of Blood Transfusion© 2016 International Society of Blood Transfusion</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-GK9RZ7N8-0/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001358 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001358 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:C3CE517249861FEC25DBB2BF205635EA45EA3B86
|texte= Transfusion risk from emerging pathogens in the Asia–Pacific region
}}
| This area was generated with Dilib version V0.6.33. |  |